Common Technical Document (CTD) Dossier Writing

BlueReg consultants can work in close collaboration with your experts to author, review and update your CTD (pharmaceutical, non-clinical and clinical) as required for new marketing authorisation application (MAA) submissions or during the lifecycle of the medicinal product. Gap analysis or conversion from Notice to Applicants (NtA) to CTD format on multiple products according to your timelines can be performed.

 

 

Our experts

Associated News